Prescription rates of protective co‐therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines
LAINE, L., CONNORS, L., GRIFFIN, M. R., CURTIS, S. P., KAUR, A., CANNON, C. P.
Published in Alimentary pharmacology & therapeutics (01.10.2009)
Published in Alimentary pharmacology & therapeutics (01.10.2009)
Get full text
Journal Article
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
Chilton, R., Tikkanen, I., Cannon, C. P., Crowe, S., Woerle, H. J., Broedl, U. C., Johansen, O. E.
Published in Diabetes, obesity & metabolism (01.12.2015)
Published in Diabetes, obesity & metabolism (01.12.2015)
Get full text
Journal Article
Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke Program
Smith, E E, Liang, L, Hernandez, A, Reeves, M J, Cannon, C P, Fonarow, G C, Schwamm, L H
Published in Neurology (01.09.2009)
Published in Neurology (01.09.2009)
Get more information
Journal Article
Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial Infarction
Cannon, Christopher P, Gibson, C. Michael, Lambrew, Costas T, Shoultz, David A, Levy, Drew, French, William J, Gore, Joel M, Weaver, W. Douglas, Rogers, William J, Tiefenbrunn, Alan J
Published in JAMA : the journal of the American Medical Association (14.06.2000)
Published in JAMA : the journal of the American Medical Association (14.06.2000)
Get full text
Journal Article
Association between white blood cell count, epicardial blood flow, Myocardial perfusion, and clinical outcomes in the setting of acute Myocardial Infarction: A Thrombolysis in Myocardial Infarction 10 Substudy
BARRON, Hal V, CANNON, Christopher P, MURPHY, Sabina A, BRAUNWALD, Eugene, GIBSON, C. Michael
Published in Circulation (New York, N.Y.) (07.11.2000)
Published in Circulation (New York, N.Y.) (07.11.2000)
Get full text
Journal Article
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs
GIBSON, C. M, CANNON, C. P, MURPHY, S. A, RYAN, K. A, MESLEY, R, MARBLE, S. J, MCCABE, C. H, VAN DE WERF, F, BRAUNWALD, E
Published in Circulation (New York, N.Y.) (18.01.2000)
Published in Circulation (New York, N.Y.) (18.01.2000)
Get full text
Journal Article
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial
CANNON, C. P, MCCABE, C. H, ALEXANDER, J. C, SKENE, A, BRAUNWALD, E, WILCOX, R. G, LANGER, A, CASPI, A, BERINK, P, LOPEZ-SENDON, J, TOMAN, J, CHARLESWORTH, A, ANDERS, R. J
Published in Circulation (New York, N.Y.) (11.07.2000)
Published in Circulation (New York, N.Y.) (11.07.2000)
Get full text
Journal Article
TIMI frame count : a quantitative method of assessing coronary artery flow
GIBSON, C. M, CANNON, C. P, BRAUNWALD, E, DALEY, W. L, DODGE, J. T, ALEXANDER, B, MARBLE, S. J, MCCABE, C. H, RAYMOND, L, FORTIN, T, POOLE, W. K
Published in Circulation (New York, N.Y.) (01.03.1996)
Published in Circulation (New York, N.Y.) (01.03.1996)
Get full text
Journal Article
Critical pathways : A review
EVERY, N. R, HOCHMAN, J, BECKER, R, KOPECKY, S, CANNON, C. P
Published in Circulation (New York, N.Y.) (01.02.2000)
Published in Circulation (New York, N.Y.) (01.02.2000)
Get full text
Journal Article
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Cannon, Christopher P, Pratley, Richard, Dagogo-Jack, Samuel, Mancuso, James, Huyck, Susan, Masiukiewicz, Urszula, Charbonnel, Bernard, Frederich, Robert, Gallo, Silvina, Cosentino, Francesco, Shih, Weichung J, Gantz, Ira, Terra, Steven G, Cherney, David Z.I, McGuire, Darren K
Published in The New England journal of medicine (08.10.2020)
Published in The New England journal of medicine (08.10.2020)
Get full text
Journal Article
Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial
Husted, S., Harrington, R. A., Cannon, C. P., Storey, R. F., Mitchell, P., Emanuelsson, H.
Published in International journal of clinical practice (Esher) (01.04.2009)
Published in International journal of clinical practice (Esher) (01.04.2009)
Get full text
Journal Article
TNK-tissue plasminogen activator in acute myocardial infarction : Results of the thrombolysis in myocardial infarction (TIMI) 10A dose-ranging trial
CANNON, C. P, MCCABE, C. H, LOVE, T. W, BRAUNWALD, E, GIBSON, C. M, GHALI, M, SEQUEIRA, R. F, MCKENDALL, G. R, BREED, J, MODI, N. B, FOX, N. L, TRACY, R. P
Published in Circulation (New York, N.Y.) (21.01.1997)
Published in Circulation (New York, N.Y.) (21.01.1997)
Get full text
Journal Article
Recent trials of lipid lowering
Ray, K. K., Cannon, C. P., Braunwald, E.
Published in International journal of clinical practice (Esher) (01.07.2007)
Published in International journal of clinical practice (Esher) (01.07.2007)
Get full text
Journal Article
National academy of clinical biochemistry laboratory medicine practice guidelines : Clinical characteristics and utilization of biochemical markers in acute coronary syndromes
Morrow, David A, Cannon, Christopher P, Jesse, Robert L, Newby, L Kristin, Ravkilde, Jan, Storrow, Alan B, Wu, Alan H B, Christenson, Robert H, Apple, Fred S, Francis, Gary, Tang, Wilson
Published in Clinical chemistry (Baltimore, Md.) (01.04.2007)
Published in Clinical chemistry (Baltimore, Md.) (01.04.2007)
Get full text
Journal Article
Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes
Antman, Elliott M, Tanasijevic, Milenko J, Thompson, Bruce, Thompson, Christopher, Schactman, Mark, McCabe, Carolyn H, Cannon, Christopher P, Fischer, George A, Fung, Anthony Y, Wybenga, Donald, Braunwald, Eugene
Published in The New England journal of medicine (31.10.1996)
Published in The New England journal of medicine (31.10.1996)
Get full text
Journal Article
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL) – A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: trial design, recruitment and baseline characteristics
Get full text
Journal Article